Diagnosis test possible - biomarkers found for ALS
There is no cure for Amyotrophic lateral sclerosis (ALS), sometimes called Lou Gehrig's disease, and until now, there has been no diagnosis for it either.
February 2006
Rilutek Will Gain Competition
Scientists at Mount Sinai School of Medicine have identified the first biomarkers for amyotrophic lateral sclerosis (ALS). These findings pave the way for a reliable test that will identify ALS sufferers at an earlier stage of the disease, and give more chances to companies developing disease-modifying drugs.
Immunosuppression Impact on the Metabolic Control of Kidney Transplant With Pre-Existing Type 2 Diabetes (DM)
Conditions: Kidney Transplant; Diabetes Mellitus, Type 2; Diabetic Nephropathy
Interventions: Drug: Cyclosporin; Drug: Tacrolimus; Behavioral: 'Diabetes Education / Management'
Sponsor: Stanford University
Completed - verified November 2016
Interventions: Drug: Cyclosporin; Drug: Tacrolimus; Behavioral: 'Diabetes Education / Management'
Sponsor: Stanford University
Completed - verified November 2016
High-Dose Immunosuppression and Autologous Transplantation for Multiple Sclerosis (HALT MS) Study
Conditions: Multiple Sclerosis (MS); Relapsing-Remitting Multiple Sclerosis
Interventions: Drug: Granulocyte-colony stimulating factor (G-CSF) and prednisone; Drug: Carmustine, etoposide, cytarabine, and melphalan (BEAM); Procedure: Autologous hematopoietic stem cell transplant
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Immune Tolerance Network (ITN)
Completed - verified November 2016
Interventions: Drug: Granulocyte-colony stimulating factor (G-CSF) and prednisone; Drug: Carmustine, etoposide, cytarabine, and melphalan (BEAM); Procedure: Autologous hematopoietic stem cell transplant
Sponsors: National Institute of Allergy and Infectious Diseases (NIAID); Immune Tolerance Network (ITN)
Completed - verified November 2016